Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2025 01:00 ET | Source: Genespire

Genespire announces oral presentation at the ASGCT Annual Meeting detailing preclinical insights into dosing for first-in-human in vivo liver-directed ISLV gene therapy for MMA

Milan, ITALY – 8 May 2025 – Genespire, a biotechnology company developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases, today announces an upcoming oral...
September 12, 2024 07:00 ET | Source: Genespire

Genespire appoints Karen Aiach-Pignet as Chief Executive Officer

PRESS RELEASE Genespire appoints Karen Aiach-Pignet as Chief Executive Officer Karen’s appointment bolsters Genespire’s position as a leader in in-vivo lentiviral gene therapy Milan, Italy, 12...
September 12, 2024 01:00 ET | Source: Genespire

Genespire appoints Karen Aiach-Pignet as Chief Executive Officer

PRESS RELEASE Genespire appoints Karen Aiach-Pignet as Chief Executive Officer Karen’s appointment bolsters Genespire’s position as a leader in in-vivo lentiviral gene therapy Milan, Italy, 12...
May 09, 2024 12:00 ET | Source: Genespire

Genespire Presents Positive Preclinical Proof of Concept Data at the ASGCT Annual Meeting

PRESS RELEASE Genespire Presents Positive Preclinical Proof of Concept Data at the ASGCT Annual Meeting Data provides preclinical validation for Genespire’s liver-directed lentiviral gene therapy in...
July 30, 2020 07:00 ET | Source: Genespire

Genespire appoints Jörn Aldag as Chairman of the Board of Directors

Genespire appoints Jörn Aldag as Chairman of the Board of DirectorsSerial entrepreneur brings exceptional experience from a range of leadership roles Italy, Milan, 30 July 2020: Genespire, a gene...